News - Boardroom

Filter

Current filters:

Boardroom

Popular Filters

51 to 75 of 100 results

Ipsen implements new US governance to prepare for Somatuline launch in oncology

Ipsen implements new US governance to prepare for Somatuline launch in oncology

22-01-2014

French drugmaker Ipsen (Euronext: IPN) has announced new governance in the USA following its decision…

BoardroomIpsenOncologyPharmaceuticalSomatulineUSA

Swedish company Dilaforette announces Sobi’s Christina Herder as new CEO

22-01-2014

Swedish drug development company Dilaforette has named Christina Herder as its new chief executive.

BoardroomDilaforetteHematologyNorthern EuropePharmaceuticalSobi

Takeda appointments former GSK exec as head if CNS research

Takeda appointments former GSK exec as head if CNS research

15-01-2014

Takeda Pharmaceutical, Japan’s largest drug company, has appointed Emiliangelo Ratti as head of its…

BoardroomManagementPharmaceuticalTakeda Pharmaceuticals

Actavis restructures, appointing industry veterans to lead US Specialty Brands business units

Actavis restructures, appointing industry veterans to lead US Specialty Brands business units

14-01-2014

US generics and specialty drugmaker Actavis has announced an updated business structure for its US Specialty…

ActavisBoardroomGenericsManagement

Amneal appoints former Warner Chilcott senior VP Rochelle Fuhrmann as CFO

14-01-2014

Privately-held US generics drugmaker Amneal has announced Rochelle Fuhrmann has joined the company as…

Amneal PharmaBoardroomGenericsUSAWarner Chilcott

ShangPharma appoints pharmaceutical executive Mitchell Reff as chief biologics officer

13-01-2014

China-based ShangPharma has named Mitchell Reff as the company’s chief biologics officer.

BoardroomChinaPharmaceuticalShangPharma

Herve Hoppenot quits Novartis to join Incyte

Herve Hoppenot quits Novartis to join Incyte

13-01-2014

Swiss drug major Novartis said on Sunday (January 12), that Herve Hoppenot, president of Novartis Oncology,…

BoardroomIncyteManagementNovartisPharmaceutical

Ipsen recruits executive VP, technical operations

Ipsen recruits executive VP, technical operations

10-01-2014

French drugmaker Ipsen has appointed Jonathan Barnsley as executive vice president in charge of technical…

BoardroomIpsenManagementPharmaceutical

Heptares appoints former GSK research head Tim Tasker as CMO

Heptares appoints former GSK research head Tim Tasker as CMO

10-01-2014

UK-based drug company Heptares Therapeutics has appointed Tim Tasker as chief medical officer and vice…

BoardroomHeptares TherapeuticsPharmaceuticalUK

Priaxon AG appoints Constance Hoefer as chief development officer

Priaxon AG appoints Constance Hoefer as chief development officer

09-01-2014

German privately-owned pharma company Priaxon AG has appointed Constance Hoefer as chief development…

BoardroomGermanyPharmaceuticalPriaxon

Teva confirms appointment of Erez Vigodman as president and CEO

Teva confirms appointment of Erez Vigodman as president and CEO

09-01-2014

Somewhat sooner than expected, Isael’s Teva Pharmaceutical Industries, the world’s largest generics…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Merck Serono appoints Steven Hildemann as global chief medical officer

Merck Serono appoints Steven Hildemann as global chief medical officer

09-01-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA (MRK: DE), has named Steven Hildemann as global…

BiotechnologyBoardroomGermanyMerck Serono

Promedior appoints William Hodder as vice president of business development

08-01-2014

US biotech company Promedior has announced that industry veteran William Hodder has joined the company…

BiotechnologyBoardroomPromediorUSA

Blend Therapeutics names former GSK VP Richard Wooster as chief scientific officer

Blend Therapeutics names former GSK VP Richard Wooster as chief scientific officer

07-01-2014

US biopharmaceutical company Blend Therapeutics has appointed pharmaceutical industry veteran Richard…

Blend TherapeuticsBoardroomGlaxoSmithKlinePharmaceuticalUSA

Teva looks set to name Erez Vigodman as new CEO

Teva looks set to name Erez Vigodman as new CEO

07-01-2014

Speculation is mounting that Israel’s Teva Pharmaceutical Industries is about to appoint a new chief…

BoardroomGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

AEterna Zentaris names Richard Sachse as chief scientific officer

04-01-2014

Canadian drugmaker AEterna Zentaris (TSX: AEZ) has appointed Richard Sachse as senior vice president,…

AEterna ZentarisBoardroomManagementPharmaceutical

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

04-01-2014

US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India…

BoardroomGenericsManagementMylan Laboratories

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Kemal Malik appointed Bayer board member with responsibility for innovation

Kemal Malik appointed Bayer board member with responsibility for innovation

20-12-2013

The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik…

BayerBiotechnologyBoardroomGermanyPharmaceuticalUK

Dominique Brard joins Ipsen as Executive Vice President of Human Resources

Dominique Brard joins Ipsen as Executive Vice President of Human Resources

19-12-2013

French pharmaceutical company Ipsen has announced the appointment of Dominique Brard as Executive Vice…

BoardroomEuropeIpsenNeurologicalOncologyPharmaceutical

Clarity appoints Alan Taylor as new Executive Chairman to the board

Clarity appoints Alan Taylor as new Executive Chairman to the board

19-12-2013

Sydney-based companion diagnostic and personalized medicine company Clarity has appointed Alan Taylor…

AustraliaBoardroomClarityPharmaceutical

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

18-12-2013

When it comes to being different, privately-owned Ferring Pharma is proud of its culture of enterprise…

BoardroomFerring PharmaceuticalsInterviewsNorthern EuropePharmaceuticalReproductive

Pfizer names Albert Bourla as group president as Amy Schulman steps down

Pfizer names Albert Bourla as group president as Amy Schulman steps down

18-12-2013

Changes in Pfizer’s (NYSE: PFE) executive leadership have been announced this week.

BoardroomPfizerPharmaceuticalUSA

Lophius Biosciences Appoints Dr Robert Phelps as director of business operations

16-12-2013

German biotechnology company Lophius Biosciences GmbH has announced that Dr Robert Phelps has joined…

Antibiotics and Infectious diseasesBiotechnologyBoardroomEuropeImmunologicals

51 to 75 of 100 results

Back to top